Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03433417 · ClinicalTrials.gov registry record · NA
Performance Evaluation of the truSculpt Radiofrequency Device for Lipolysis of Abdominal Fat
A NA study of Body Fat, sponsored by Cutera.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT03433417: Completed NA study of Body Fat, sponsored by Cutera.
NCT03433417 is a NA study of Body Fat that has completed, run by Cutera. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03433417, a NA study of Body Fat, has completed, sponsored by Cutera.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
Clinical Study to Evaluate the Performance the truSculpt Radiofrequency Device for Lipolysis of Abdominal Fat
Primary Outcome
Descriptive histological evaluation of abdominal tissue for selective fat necrosis, with sparing of the dermis and epidermis, following one truSculpt treatment vs. untreated bilateral control. A responder is a biopsy sample that shows necrosis or inflammatory immune cell response.
Conditions Studied
Interventions
- DEVICE Cutera truSculpt
Study Locations (1)
California
- Cutera Research Center - Brisbane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-06-15 |
| Est. Completion | 2018-03-15 |
| Phase | NA |
What the finished NCT03433417 record still lists
NCT03433417 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Body Fat appearing as the primary indexed condition, and to 1 intervention - of which Cutera truSculpt is the first listed.
NCT03433417 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03433417 about?
NCT03433417 is a clinical study titled "Performance Evaluation of the truSculpt Radiofrequency Device for Lipolysis of Abdominal Fat". Clinical Study to Evaluate the Performance the truSculpt Radiofrequency Device for Lipolysis of Abdominal Fat
What is the current status of trial NCT03433417?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2017-06-15. Estimated completion is 2018-03-15.
What conditions does trial NCT03433417 study?
This clinical trial studies the following conditions: Body Fat.
What interventions are being tested in trial NCT03433417?
The interventions under investigation include: Cutera truSculpt (DEVICE).
Who is sponsoring clinical trial NCT03433417?
This trial is sponsored by Cutera, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03433417 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Body Fat
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03433417's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI